413 related articles for article (PubMed ID: 1645609)
1. Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution.
Liu-Chen LY; Li SX; Lewis ME
Brain Res; 1991 Mar; 544(2):235-42. PubMed ID: 1645609
[TBL] [Abstract][Full Text] [Related]
2. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
3. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
4. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
Tam SW; Liu-Chen LY
J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
[TBL] [Abstract][Full Text] [Related]
5. [3H] beta-funaltrexamine ([3H] beta-FNA) binds irreversibly to mu opioid receptors in the rat brain: autoradiographic study.
Liu-Chen LY; Li SX; Rohrbach KW; Lewis ME
Prog Clin Biol Res; 1990; 328():61-4. PubMed ID: 2154819
[No Abstract] [Full Text] [Related]
6. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
[TBL] [Abstract][Full Text] [Related]
7. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
Liu-Chen LY; Li SX; Tallarida RJ
Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
Rothman RB; Bykov V; Long JB; Brady LS; Jacobson AE; Rice KC; Holaday JW
Eur J Pharmacol; 1989 Jan; 160(1):71-82. PubMed ID: 2540993
[TBL] [Abstract][Full Text] [Related]
9. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain.
Mansour A; Khachaturian H; Lewis ME; Akil H; Watson SJ
J Neurosci; 1987 Aug; 7(8):2445-64. PubMed ID: 3039080
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
12. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
Martin TJ; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1993 Oct; 267(1):506-14. PubMed ID: 8229781
[TBL] [Abstract][Full Text] [Related]
13. Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine.
Liu-Chen LY; Phillips CA
Mol Pharmacol; 1987 Sep; 32(3):321-9. PubMed ID: 2823089
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824.
Rothman RB; Jacobson AE; Rice KC; Herkenham M
Peptides; 1987; 8(6):1015-21. PubMed ID: 2831515
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.
Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G
Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).
Ward SJ; Fries DS; Larson DL; Portoghese PS; Takemori AE
Eur J Pharmacol; 1985 Jan; 107(3):323-30. PubMed ID: 2984010
[TBL] [Abstract][Full Text] [Related]
17. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
Dissanayake VU; Hughes J; Hunter JC
Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
[TBL] [Abstract][Full Text] [Related]
18. Binding of [3H][D-Ala2, MePhe4, Gly-ol5] enkephalin, [3H][D-Pen2, D-Pen5]enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats.
Bhargava HN; Villar VM; Cortijo J; Morcillo EJ
Peptides; 1997; 18(10):1603-8. PubMed ID: 9437722
[TBL] [Abstract][Full Text] [Related]
19. Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor.
Chen C; Xue JC; Zhu J; Chen YW; Kunapuli S; Kim de Riel J; Yu L; Liu-Chen LY
J Biol Chem; 1995 Jul; 270(30):17866-70. PubMed ID: 7629089
[TBL] [Abstract][Full Text] [Related]
20. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
